Tin tức & Cập nhật

Individuals who have trouble falling asleep and who use sleep medications are at increased risk of dementia, as reported in a study.

Using methylphenidate and a selective serotonin reuptake inhibitor (SSRI) together does not appear to pose any significant risk, with both agents having been shown to be safe in adolescent patients with attention deficit-hyperactivity disorder (ADHD) and depression, according to a new-user cohort study.

Treatment with lanadelumab given every 2 or 4 weeks (Q2W or Q4W dosing) reduces the frequency of attacks in patients aged 2 to <12 years with hereditary angioedema (HAE), according to the SPRING study presented at AAAAI 2023.

The use of the novel selective JAK-1 inhibitor upadacitinib appears to result in rapid symptom improvements in patients with difficult-to-treat ulcerative colitis or Crohn’s disease, including those who have prior exposure to tofacitinib, according to real-world data.

Treatment with hydrochlorothiazide, regardless of dose, does not appear to significantly reduce the incidence of kidney stone recurrence as compared with placebo, according to a study.

A treat-to-target low-density lipoprotein cholesterol (LDL-C) strategy of 50–70 mg/dL appears to be comparable to a high-intensity statin therapy in terms of preventing major adverse cardiac and cerebrovascular events in patients with coronary artery disease, according to a study.